Your browser doesn't support javascript.
loading
Saliva-Based ELISAs for Effective SARS-CoV-2 Antibody Monitoring in Vaccinated Individuals.
Casian, Joseph G; Angel, Aaron N; Lopez, Ronell; Bagos, Cedie; MacMullan, Melanie A; Bui, Mindy L; Chellamathu, Prithivi; Das, Sudipta; Turner, Fred; Slepnev, Vladimir; Ibrayeva, Albina.
Afiliação
  • Casian JG; Department of Serology Research and Development, Curative, Monrovia, CA, United States.
  • Angel AN; Department of Serology Research and Development, Curative, Monrovia, CA, United States.
  • Lopez R; Department of Serology Research and Development, Curative, Monrovia, CA, United States.
  • Bagos C; Department of Serology Research and Development, Curative, Monrovia, CA, United States.
  • MacMullan MA; Department of Serology Research and Development, Curative, Monrovia, CA, United States.
  • Bui ML; Mork Family Department of Chemical Engineering and Materials Science, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, United States.
  • Chellamathu P; Department of Serology Research and Development, Curative, Monrovia, CA, United States.
  • Das S; Department of Serology Research and Development, Curative, Monrovia, CA, United States.
  • Turner F; Department of Serology Research and Development, Curative, Monrovia, CA, United States.
  • Slepnev V; Department of Serology Research and Development, Curative, Monrovia, CA, United States.
  • Ibrayeva A; Department of Serology Research and Development, Curative, Monrovia, CA, United States.
Front Immunol ; 12: 701411, 2021.
Article em En | MEDLINE | ID: mdl-34539632
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Saliva / Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Saliva / Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article